Koninklijke Philips Stock (NYSE:PHG)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$25.96

52W Range

$19.49 - $32.91

50D Avg

$30.30

200D Avg

$25.91

Market Cap

$24.25B

Avg Vol (3M)

$818.55K

Beta

0.79

Div Yield

$0.92 (3.74%)

PHG Company Profile


Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

Yes

Country

NL

Employees

69,282

IPO Date

Mar 17, 1980

Website

PHG Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 22Dec 21Dec 20
China€2.19B€2.33B€2.43B
Japan€1.08B€1.07B€1.31B
United Kingdom of Great Britain and Northern Ireland€463.00M€481.00M-
Netherlands€540.00M€570.00M€555.00M
Germany€821.00M€839.00M€1.11B
France€400.00M€397.00M€545.00M
Other countries€5.08B€5.04B€6.43B
United States of America€7.25B€6.42B€6.64B
Korea (Republic of)--€509.00M

Fiscal year ends in Dec 23 | Currency in EUR

PHG Financial Summary


Dec 23Dec 22Dec 21
Revenue€18.17B€17.83B€17.16B
Operating Income€-115.00M€-116.00M€553.00M
Net Income€-466.00M€-1.62B€612.00M
EBITDA€1.03B€1.49B€2.02B
Basic EPS€-0.49€-1.84€0.64
Diluted EPS€-0.49€-1.84€0.64

Fiscal year ends in Dec 23 | Currency in EUR

Latest Earnings Call Transcripts


Q3 24Oct 28, 24 | 9:41 AM
Q2 24Jul 29, 24 | 12:59 PM
Q1 24Apr 29, 24 | 9:44 AM

Peer Comparison


TickerCompany
ZBHZimmer Biomet Holdings, Inc.
ABTAbbott Laboratories
BRKRBruker Corporation
ITGRInteger Holdings Corporation
PODDInsulet Corporation
SYKStryker Corporation
ZIMVZimVie Inc.
EWEdwards Lifesciences Corporation
MDTMedtronic plc
STESTERIS plc
GMEDGlobus Medical, Inc.
GKOSGlaukos Corporation
NVCRNovoCure Limited
NARIInari Medical, Inc.
SNNSmith & Nephew plc
BIOBio-Rad Laboratories, Inc.
INSPInspire Medical Systems, Inc.
CNMDCONMED Corporation